Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (141-150 of 715) with videos related to

Pageof 72
Sort By:
Thrombosis Research|September 15, 1986
Stimulation by heparin of the plasmin-mediated conversion of single-chain to two-chain urokinase-type plasminogen activatorH R Lijnen, D Collen
Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
Tissue-type plasminogen activator: a historical perspective and personal accountD Collen, H R Lijnen
Biochimica Et Biophysica Acta|July 7, 1978
Neoantigenic expression in enzyme-inhibitor complexes. A means to demonstrate activation of enzyme systemsD Collen, F de Cock
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1989
New developments in thrombolytic therapyD Collen, H K Gold
The American Journal of Cardiology|December 16, 1993
On the future of thrombolytic therapy for acute myocardial infarctionD Collen, H R Lijnen
The Journal of Biological Chemistry|July 10, 1981
Purification and characterization of the plasminogen activator secreted by human melanoma cells in cultureD C Rijken, D Collen
Thrombosis and Haemostasis|July 12, 1991
Strategies for the improvement of thrombolytic agentsH R Lijnen, D Collen
Biotechnology Advances|January 1, 1993
Development of thrombolytic agentsH R Lijnen, D Collen
European Heart Journal|August 9, 2001
Antibodies against oxidized LDL for non-invasive diagnosis of atherosclerotic vascular diseaseB de Geest, D Collen
Seminars in Thrombosis and Hemostasis|January 1, 1982
Interaction of plasminogen activators and inhibitors with plasminogen and fibrinH R Lijnen, D Collen
Pageof 72

Showing results (141-150 of 715) with videos related to

Sort By:
Pageof 72
Thrombosis Research|September 15, 1986
Stimulation by heparin of the plasmin-mediated conversion of single-chain to two-chain urokinase-type plasminogen activatorH R Lijnen, D Collen
Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
Tissue-type plasminogen activator: a historical perspective and personal accountD Collen, H R Lijnen
Biochimica Et Biophysica Acta|July 7, 1978
Neoantigenic expression in enzyme-inhibitor complexes. A means to demonstrate activation of enzyme systemsD Collen, F de Cock
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1989
New developments in thrombolytic therapyD Collen, H K Gold
The American Journal of Cardiology|December 16, 1993
On the future of thrombolytic therapy for acute myocardial infarctionD Collen, H R Lijnen
The Journal of Biological Chemistry|July 10, 1981
Purification and characterization of the plasminogen activator secreted by human melanoma cells in cultureD C Rijken, D Collen
Thrombosis and Haemostasis|July 12, 1991
Strategies for the improvement of thrombolytic agentsH R Lijnen, D Collen
Biotechnology Advances|January 1, 1993
Development of thrombolytic agentsH R Lijnen, D Collen
European Heart Journal|August 9, 2001
Antibodies against oxidized LDL for non-invasive diagnosis of atherosclerotic vascular diseaseB de Geest, D Collen
Seminars in Thrombosis and Hemostasis|January 1, 1982
Interaction of plasminogen activators and inhibitors with plasminogen and fibrinH R Lijnen, D Collen
Pageof 72